Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

C4 Therapeutics (CCCC) Change in Receivables (2019 - 2026)

C4 Therapeutics has reported Change in Receivables over the past 8 years, most recently at $482000.0 for Q1 2026.

  • For Q1 2026, Change in Receivables fell 90.22% year-over-year to $482000.0; the TTM value through Mar 2026 reached -$5.1 million, up 7.63%, while the annual FY2025 figure was -$701000.0, 91.94% up from the prior year.
  • Change in Receivables for Q1 2026 was $482000.0 at C4 Therapeutics, up from -$4.1 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $11.3 million in Q4 2023 and troughed at -$12.4 million in Q2 2024.
  • A 5-year average of -$166647.1 and a median of -$63000.0 in 2022 define the central range for Change in Receivables.
  • Biggest five-year swings in Change in Receivables: soared 75433.33% in 2023 and later crashed 2586.2% in 2024.
  • Year by year, Change in Receivables stood at -$15000.0 in 2022, then soared by 75433.33% to $11.3 million in 2023, then crashed by 164.06% to -$7.2 million in 2024, then skyrocketed by 42.8% to -$4.1 million in 2025, then surged by 111.64% to $482000.0 in 2026.
  • Business Quant data shows Change in Receivables for CCCC at $482000.0 in Q1 2026, -$4.1 million in Q4 2025, and $4.3 million in Q3 2025.